The invention relates to a new application of butein, particularly to an application of butein in preparing angiogenesis inhibitory drugs for treating angiogenesis-dependent diseases such as breast cancer, colon cancer, lymphomata, acute myeloid leukemia, rheumatoid arthritis, psoriasis, diabetes syndrome, hemangioma, etc. The butein has distinct inhibitory action in both human umbilical vein endothelial cells (HUVEC) proliferation experiment, HUVEC migration experiment, HUVEC invasion experiment, human microvascular endothelial cells (HMEC-1) canalization experiment, chick embryo allantois angiogenesis, etc.; and can be used in preparing angiogenesis inhibitory drugs.